.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ACZONE Drug Profile

« Back to Dashboard
Aczone is a drug marketed by Allergan Inc and Allergan and is included in two NDAs. It is available from one supplier. There are four patents protecting this drug.

This drug has forty-four patent family members in twenty-two countries.

The generic ingredient in ACZONE is dapsone. There are seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the dapsone profile page.

Summary for Tradename: ACZONE

Patents:4
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Drug Prices: :see details

Pharmacology for Tradename: ACZONE

Ingredient-typeSulfones
Drug ClassSulfone
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Inc
ACZONE
dapsone
GEL;TOPICAL207154-001Feb 24, 2016RXYes6,060,085► subscribe ► subscribe
Allergan
ACZONE
dapsone
GEL;TOPICAL021794-001Jul 7, 2005RXYes5,863,560► subscribeY ► subscribe
Allergan Inc
ACZONE
dapsone
GEL;TOPICAL207154-001Feb 24, 2016RXYes5,863,560► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ACZONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Inc
ACZONE
dapsone
GEL;TOPICAL207154-001Feb 24, 20166,620,435► subscribe
Allergan
ACZONE
dapsone
GEL;TOPICAL021794-001Jul 7, 20055,863,560► subscribe
Allergan Inc
ACZONE
dapsone
GEL;TOPICAL207154-001Feb 24, 20166,060,085► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ACZONE

Country Document Number Estimated Expiration
MexicoPA02006593► subscribe
Portugal957900► subscribe
Portugal1485059► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc